▼ 2.16%
prev close
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Congressional Trades
1
All tracked trades
Members Trading
1
Unique members
Net Activity
-1
0 buys · 1 sells
Members Who Traded This Stock
1 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2023-07-10 | FMSFresenius Medical Care AG | Sell | $1,001 - $15,000 | 1164d ago | — |
2023-07-10
Daniel Goldman
FMS
Amount
$1,001 - $15,000
Filed
1164d ago
Recent News
Powered by Polygon.io
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now
New Cross-Study Analysis from Spherix Global Insights Combines Physician, Dietitian and Patient Chart Data to Show Access Barriers Still Curbing Xphozah Uptake Ahead of the TDAPA Cliff
Urology Devices Market Size to Reach USD 80.0 Billion by 2035 | SNS Insider
Trade Timeline
Congressional activity, newest first
Daniel Goldman
2023-07-10 · Sale
$1,001 - $15,000